C9orf72 and amyotrophic lateral sclerosis: More specifically, impairment in executive oculomotor control was primarily observed in C9orf72 repeat expansion carriers, long before any overt clinical signs of ALS or FTD pathologies known to be associated with C9orf72 mutations.